index - Myopathies inflammatoires & thérapies innovantes ciblées Accéder directement au contenu

Dernières publications

Chiffres clés

121 Publications avec texte intégral

Open Access

53 %

Mots clés

Dependovirus/genetics/immunology Antibodies Sphingosine-1-phosphate Aldosterone Aged Active B cell homeostasis Female Biomarker Anti‐mitochondrial antibodies Antisynthetase Anti-drug antibodies AAV Amyotrophic lateral sclerosis Myositis Immune checkpoint inhibitors Autoantibodies Myocarditis Auto-antibodies Muscle Multidisciplinarity Immunotherapy Adeno-associated virus vector Bioelectrical impedance analysis Anti-agalsidase antibodies Adult Antiphospholipid syndrome Adolescence IMNM Myositis and muscle disease Myopathy Anti-MDA5 autoantibodies Humans Adverse drug reactions AAV humoral immunity Case reports Interferon Inflammatory myopathy Acid-alpha-glucosidase CD8+T cells Biopsy Anti-synthetase syndrome Male Analyses multidimensionnelles Anticorps anti-agalsidase Autoimmunity Mass cytometry Auto-immunité COVID-19 Acute Kidney Injury/epidemiology/etiology Agalsidase Outcome measures Autoantibody Biomarqueurs Dermatomyositis Assisted communication devices Anti-interleukin-6 Fabry disease Interstitial lung disease Biomarkers Skeletal muscle Cancer Prognosis Inclusion body myositis Data integration Lysosomal storage diseases AAV vector Inborn errors of metabolism Auto‐antibodies Autoimmune diseases Inflammation Middle Aged Polymyositis Aldostérone IBM Animals Anti-IgE IgG Cytokines Adjudication Systems biology Antisynthetase syndrome Gene therapy Antibody responses Deep immune profiling Machine learning Adeno-associated virus Arthritis Idiopathic inflammatory myopathies AAV antibody Adeno-associated vector DM CD8+ T-bet+ cells Anticorps spécifique des myosites Abnormal movement Amyotrophy AAV vectors Anti-Mi2 Antisynthétase B-lymphocyte Anémie hémolytique